GYARAN HADA HADIN AYYUKAN MAI TARIN HADAWA
APPLICATION NA ANALYZER REAGENS
Masu shan magungunan rage radadi a jini ya kamata su yi taka tsantsan yayin cin ayaba. Beijing Succeeder yana taimakawa wajen gano thrombosis da kuma gano cutar hemostasis.
Sau da yawa ana ɗaukar Ayaba a matsayin 'ya'yan itace mai lafiya saboda wadataccen abinci mai gina jiki, gami da bitamin da ma'adanai. Duk da haka, ga waɗanda ke shan magungunan rage jini, Ayaba na iya zama ɓoyayyen haɗari ga lafiya.
Magungunan rage radadi na jini, kamar warfarin na yau da kullun, galibi ana amfani da su don hanawa da magance matsalolin thrombosis. Marasa lafiya da ke da yanayi kamar tiyatar maye gurbin bawul ɗin zuciya, fibrillation na atrial, da thrombosis na jijiyoyin jini na ƙananan gaɓoɓi galibi suna buƙatar amfani na dogon lokaci. Tsarin aikinsu shine hana kunna abubuwan da ke haifar da coagulation na bitamin K, wanda hakan ke rage haɗarin coagulation na jini da kuma tabbatar da santsi na zagayawar jini. Ayaba 'ya'yan itace ne mai wadataccen bitamin K, tare da kimanin microgram 10 a kowace gram 100. Vitamin K yana aiki a matsayin "mai kunna" tsarin coagulation, yana haɓaka kunna abubuwan coagulation da haɓaka coagulation na jini. Lokacin da marasa lafiya ke shan magungunan rage radadi na jini suna cin ayaba mai yawa, matakan bitamin K ɗinsu suna ƙaruwa sosai. Wannan na iya magance tasirin maganin, yana rage tasirin maganin rage radadi na jini da kuma ƙara haɗarin clotting na jini sosai. Majinyaci mai hawan jini wanda ya shafe shekaru uku yana shan warfarin ya fuskanci alamun coagulation marasa tsari bayan ya sha ayaba mai laushi tare da karin kumallo na tsawon mako guda, wanda a ƙarshe ya kai ga asibiti don bugun jini. Wannan shari'ar tana aiki a matsayin kiran farkawa ga marasa lafiya da ke shan magungunan rage radadi.
Duk da haka, wannan ba yana nufin cewa mutanen da ke shan magungunan rage radadi ya kamata su guji ayaba gaba ɗaya ba. A cewar "Ka'idojin Abinci ga Mazauna China (2022), manya ya kamata su ci gram 200-350 na 'ya'yan itace a kowace rana, kusan daidai da ayaba ɗaya zuwa biyu. Yawan shan matsakaici gabaɗaya ba ya yin tasiri sosai ga tasirin magungunan rage radadi na jini. Duk da haka, mabuɗin shine a kula da daidaitaccen abinci mai kyau da kuma guje wa manyan canje-canje a yawan shan bitamin K a cikin ɗan gajeren lokaci.
Kamfanin Beijing Succeeder Technology Inc. (lambar hannun jari: 688338) jagora ne a fannin binciken cututtukan thrombosis da hemostasis a cikin vitro. An kafa kamfanin a shekarar 2003, tsawon shekaru da yawa yana mai da hankali kan bincike, haɓakawa, samarwa, da siyar da kayan aikin bincike na in vitro da reagents don thrombosis da hemostasis. Kamfanin Beijing Succeeder yana ba wa cibiyoyin kiwon lafiya kayan aikin gwaji na atomatik, gami da coagulation, hemorheology, hematocrit, da platelet aggregation, da kuma tallafawa reagents da abubuwan da ake amfani da su. Ana amfani da samfuransa sosai wajen rigakafi, tantancewa, ganowa, da kuma sa ido kan cututtukan thrombotic da hemorrhagic, gami da bugun jini, cututtukan jijiyoyin zuciya, da thromboembolism na jijiyoyin jini.
A shekarar 2023, na'urar nazarin coagulation ta Beijing Succeeder ta sami rijistar CE ta IVDR, wadda ta ƙara nuna ƙarfin fasaharta da ingancin samfurinta a fannin binciken in vitro. Bayanan da aka fitar a ranar 17 ga watan Agusta na wannan shekarar sun nuna cewa kamfanin ya sami kuɗin shiga na aiki na Yuan miliyan 141 a rabin farko na shekara, ƙaruwar kashi 33.19% a shekara-shekara, da kuma ribar da masu hannun jari suka samu ta Yuan miliyan 60.222, ƙaruwar kashi 26.91% a shekara-shekara. Bugu da ƙari, na'urar tantance coagulation ta Beijing ta sami karramawa da dama, ciki har da zaɓenta a cikin Jerin Kamfanonin Fasaha Masu Muhimmanci na Shirin Torch na Ƙasa na 2012 wanda Cibiyar Torch ta Ma'aikatar Kimiyya da Fasaha ta buga, kuma ta kasance ta 29 a cikin Jerin Ribar Kamfanonin Bincike na In Vitro na China na 2022.
Kamfanin Beijing Succeeder, tare da samfuransa na ƙwararru da fasahohinsa, yana ba da goyon baya mai ƙarfi ga likitoci don tantance yanayin zubar jini na marasa lafiya daidai, yana taka muhimmiyar rawa wajen kare lafiyar marasa lafiya. Ga marasa lafiya da ke shan magungunan rage radadi, sa ido akai-akai tare da fasahar gwaji da samfuran da aka yi amfani da su, yayin da suke mai da hankali kan hulɗar abinci da magunguna, zai iya tabbatar da ingancin magani da lafiyar gaba ɗaya.
Kamfanin FASAHA NA BEIJING INC.
КОНЦЕНТРАЦИЯ СЕРВИС КОАГУЛЯЦИЯ
АНАЛИЗАТОР РЕАГЕНТОВ ПРИМЕНЕНИЕ
Katin kasuwanci
WeChat na kasar Sin